Vray, Muriel <br/><br/>
Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).  [electronic resource] 

 -  Antiviral therapy  Oct 2003 
 - 427-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1359-6535 
<br/><br/><label>Standard No.: </label>10.1177/135965350300800510  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--pharmacology<br/>Drug Resistance, Viral--genetics<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV Protease--genetics<br/>HIV Protease Inhibitors--pharmacology<br/>HIV Reverse Transcriptase--genetics<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Phenotype<br/>Predictive Value of Tests<br/>RNA, Viral--blood<br/>Reverse Transcriptase Inhibitors--pharmacology<br/>Treatment Outcome<br/>Viral Load